Meghmani Organics standalone profit rises 42% in Q1FY27 on margin gains
Meghmani Organics Ltd posted a 42% YoY increase in standalone net profit to ₹57.6 crore for Q1FY27, supported by a 16% rise in EBITDA to ₹93.7 crore and margin expansion to 17.9%. While revenue declined 12% due to soft demand, profitability improved via better pricing. The NCLT approved the amalgamation of two subsidiaries into the parent entity.
*this image is generated using AI for illustrative purposes only.
Meghmani Organics reported a consolidated net profit of ₹481.94 lakh for Q1FY27, a 280% year-on-year increase, while standalone net profit grew 42% to ₹57.6 crore. The improvement was driven by an EBITDA margin expansion to 17.9% from 13.6%, despite an 11.50% decline in consolidated revenue to ₹5,428.30 lakh. Concurrently, the National Company Law Tribunal (NCLT) approved the amalgamation of subsidiaries Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited into the parent entity.
The Board of Directors approved the unaudited financial results on July 29, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and subjected to limited review by statutory auditors Mukesh M. Shah & Co., Chartered Accountants. Naresh Prajapati was appointed as Company Secretary and Compliance Officer effective July 29, 2026.
Financial Performance Highlights
Standalone revenue from operations declined 12% year-on-year to ₹522.9 crore, primarily due to softer demand amid macroeconomic uncertainties. However, operational leverage improved bottom-line metrics significantly. Standalone EBITDA grew 16% to ₹93.7 crore, with margins expanding to 17.9% from 13.6% in Q1FY26. The divergence between standalone and consolidated profitability highlights the impact of inter-company eliminations and subsidiary performance on group-level metrics.
| Metric: | Consolidated Q1FY27 | Consolidated Q1FY26 | Standalone Q1FY27 | Standalone Q1FY26 |
|---|---|---|---|---|
| Revenue from Operations (₹ Lakh): | 5,428.30 | 6,136.24 | 52,290.00 | 59,260.00 |
| Net Profit (₹ Lakh): | 481.94 | 126.83 | 5,760.00 | 4,050.00 |
| EPS - Basic (₹): | 1.90 | 0.50 | 2.26 | 1.59 |
| EBITDA Margin: | 18% | 10.90% | 17.9% | 13.6% |
Segment-Wise Breakdown
The Crop Protection segment remained the primary revenue driver, contributing approximately 75% of overall revenue with ₹391.6 crore and an EBITDA of ₹77.8 crore. Its EBITDA margin stood at 19.9%, with capacity utilisation at 63%. The Pigments segment generated ₹131.3 crore in revenue, constituting ~25% of the total, with an EBITDA of ₹15.9 crore and a margin of 12.1%. Capacity utilisation for Pigments stood at 39%. Operations in Titanium Dioxide remain suspended due to commercial unviability arising from elevated raw material costs and weaker price realisations following the withdrawal of anti-dumping duty.
Corporate Developments
The Scheme of Amalgamation of Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited into Meghmani Organics Limited received approval from the Hon’ble NCLT, Ahmedabad Bench. Shareholder and creditor votes were held between June 3 and June 5, 2026. The second motion petition was filed before the NCLT on July 2, 2026. The amalgamation aims to simplify the group structure, derive operational synergies, and eliminate duplicate compliances.
What the Numbers Show
The near-doubling of the standalone EBITDA margin despite a 12% revenue decline indicates strong operational efficiency gains through better price realisation and favourable product mix. Management expects growth momentum to continue with positive contributions from newly introduced nano fertiliser products, including Nano DAP, Nano NPK, and Nano Zinc.
Historical Stock Returns for Meghmani Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.30% | +5.86% | +19.33% | -0.31% | -39.54% | -35.47% |
How will the NCLT-approved amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition accelerate operational synergies and reduce compliance costs in the medium term?
What is the projected revenue contribution timeline for the newly launched nano fertiliser products (Nano DAP, Nano NPK, Nano Zinc) to offset the current decline in standalone revenue?
Given the suspension of Titanium Dioxide operations due to anti-dumping duty withdrawal, what is management's strategic roadmap for restarting production or exiting this segment?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
